Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for RenovoRx Inc have a median target of 5.50, with a high estimate of 8.25 and a low estimate of 3.50. The median estimate represents a 458.94% increase from the last price of 0.984.
High | 738.4% | 8.25 |
Med | 458.9% | 5.50 |
Low | 255.7% | 3.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 14, 2024.
Average growth rate | -15.75% |
Average growth rate | +9.55% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼